Analysed JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) News Sources
Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA
31-08-2026
yahoo.com
Stocks making big moves yesterday: Jazz Pharmaceuticals, SAIC, Herbalife, AGCO, and Deere
01-09-2026
yahoo.com
Duncan Ferguson Joins Neovii Pharmaceuticals AG to Lead Global Commercial Expansion as Chief Commercial Officer
01-09-2026
yahoo.com
Jazz (JAZZ) Says Ziihera Beat Trastuzumab on Overall Survival. Can it Replace the First-Line HER2 Backbone?
04-09-2026
yahoo.com
Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says
11-09-2026
yahoo.com
What is the current price of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)?
The current price of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) is $240.83.
JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) since the previous trading day is $-5.04.
JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) since the previous trading day is -2.0499%.
What is the most recent average sentiment score for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)?
The most recent average sentiment score for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)?
The most recent sentiment for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) is .
SEC-8K** Filing Available For JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.